218 related articles for article (PubMed ID: 37000318)
1. Acquired von willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: long-term remission after treatment with bortezomib.
Saldanha A; Veiga ME; Okazaki E; Rothschild C; Martinez G; Rocha V; Orsi FA; Villaca P
J Thromb Thrombolysis; 2023 May; 55(4):770-774. PubMed ID: 37000318
[TBL] [Abstract][Full Text] [Related]
2. Lenalidomide as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy.
Lavin M; Brophy TM; Rawley O; O'Sullivan JM; Hayden PJ; Browne PV; Ryan K; O'Connell N; O'Donnell JS
J Thromb Haemost; 2016 Jun; 14(6):1200-5. PubMed ID: 26991062
[TBL] [Abstract][Full Text] [Related]
3. Successful use of lenalidomide to treat refractory acquired von Willebrand disease associated with monoclonal gammopathy.
Green A; Shen YP; Nelson AT; Sarode R; Ibrahim IF; Cao J; Afraz S; Yates SG
Ann Hematol; 2022 Dec; 101(12):2627-2631. PubMed ID: 36194257
[TBL] [Abstract][Full Text] [Related]
4. Acquired von Willebrand syndrome in a patient with monoclonal gammopathy of undetermined significance.
Puronen CE; Josephson NC; Broudy VC
Blood Coagul Fibrinolysis; 2013 Jun; 24(4):430-2. PubMed ID: 23249617
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of acquired von Willebrand syndrome associated with monoclonal gammopathy : Breaking a dangerous bond.
Jeryczynski G; Agis H; Eichinger-Hasenauer S; Krauth MT
Wien Klin Wochenschr; 2022 Jun; 134(11-12):478-482. PubMed ID: 35305139
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches.
Federici AB; Stabile F; Castaman G; Canciani MT; Mannucci PM
Blood; 1998 Oct; 92(8):2707-11. PubMed ID: 9763553
[TBL] [Abstract][Full Text] [Related]
7. Myeloma and monoclonal gammopathy of uncertain significance associated with acquired von Willebrand's syndrome. Seven new cases with a literature review.
Lamboley V; Zabraniecki L; Sie P; Pourrat J; Fournié B
Joint Bone Spine; 2002 Jan; 69(1):62-7. PubMed ID: 11858359
[TBL] [Abstract][Full Text] [Related]
8. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
[TBL] [Abstract][Full Text] [Related]
9. Distinct mechanisms account for acquired von Willebrand syndrome in plasma cell dyscrasias.
Dicke C; Schneppenheim S; Holstein K; Spath B; Bokemeyer C; Dittmer R; Budde U; Langer F
Ann Hematol; 2016 May; 95(6):945-57. PubMed ID: 27040683
[TBL] [Abstract][Full Text] [Related]
10. Acquired von Willebrand syndrome and lymphoid neoplasms: A review of malignancy management, and propositions of practical recommendations.
Nicol C; Pan-Petesch B; Ianotto JC
Haemophilia; 2022 Nov; 28(6):938-949. PubMed ID: 36006003
[TBL] [Abstract][Full Text] [Related]
11. IgG kappa monoclonal gammopathy of undetermined significance presenting as acquired type III Von Willebrand syndrome.
Howard CR; Lin TL; Cunningham MT; Lipe BC
Blood Coagul Fibrinolysis; 2014 Sep; 25(6):631-3. PubMed ID: 24686099
[TBL] [Abstract][Full Text] [Related]
12. Response comparison of multiple myeloma and monoclonal gammopathy of undetermined significance to the same anti-myeloma therapy: a retrospective cohort study.
Campbell JP; Heaney JLJ; Pandya S; Afzal Z; Kaiser M; Owen R; Child JA; Cairns DA; Gregory W; Morgan GJ; Jackson GH; Bunce CM; Drayson MT
Lancet Haematol; 2017 Dec; 4(12):e584-e594. PubMed ID: 29146225
[TBL] [Abstract][Full Text] [Related]
13. Acquired von Willebrand syndrome in patients with monoclonal gammopathy of undetermined significance investigated using a mechanistic approach.
Galletta E; Galvanin F; Bertomoro A; Daidone V; Casonato A
Blood Transfus; 2023 Jan; 21(1):74-82. PubMed ID: 34694218
[TBL] [Abstract][Full Text] [Related]
14. [Rare manifestations of monoclonal gammopathies: About two clinical cases and literature review].
Perlot Q; Hermans C; Vekemans MC
Rev Med Interne; 2023 Jun; 44(6):307-310. PubMed ID: 37005096
[TBL] [Abstract][Full Text] [Related]
15. Type 1 Cryoglobulinemic Vasculitis Due to Monoclonal Gammopathy of Undetermined Significance Successfully Treated by Bortezomib Plus Dexamethasone.
Kikuchi R; Onozawa M; Nagai J; Okada S; Hasegawa Y; Ohigashi H; Mitamura S; Maeda T; Takakuwa E; Fujieda Y; Goto H; Hashimoto D; Matsuno Y; Teshima T
Intern Med; 2024 Feb; 63(4):541-545. PubMed ID: 37316269
[TBL] [Abstract][Full Text] [Related]
16. Acquired von Willebrand syndrome in association with multiple myeloma: remission after stem cell transplant.
Shah CP; Delaune J; Mandernach MW
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33504531
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib effectiveness in one patient with acquired von Willebrand syndrome associated to monoclonal gammopathy of undetermined significance.
Ojeda-Uribe M; Caron C; Itzhar-Baikian N; Debliquis A
Am J Hematol; 2010 May; 85(5):396. PubMed ID: 20425807
[No Abstract] [Full Text] [Related]
18. Pharmacokinetic studies with FVIII/von Willebrand factor concentrate can be a diagnostic tool to distinguish between subgroups of patients with acquired von Willebrand syndrome.
Luboshitz J; Lubetsky A; Schliamser L; Kotler A; Tamarin I; Inbal A
Thromb Haemost; 2001 May; 85(5):806-9. PubMed ID: 11372672
[TBL] [Abstract][Full Text] [Related]
19. [Acquired von Willebrand syndrome in three patients and literature review].
Ouyang HY; Yu ZJ; Yin J; Zhao XJ; Wang ZY; Zhang W; Ma ZN; Su J; Bai X; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):692-5. PubMed ID: 27587252
[TBL] [Abstract][Full Text] [Related]
20. Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):577-88. PubMed ID: 16977568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
